Cargando…

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19

Detalles Bibliográficos
Autores principales:	Kumar, Pramod, Kulkarni, Anand, Sharma, Mithun, Rao, Padaki N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546995/ https://www.ncbi.nlm.nih.gov/pubmed/33071519 http://dx.doi.org/10.1016/j.jceh.2020.10.001

Ejemplares similares

Pathogenesis of Liver Injury in Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2020)

Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2–related Acute-on-chronic Liver Failure
por: Kumar, Pramod, et al.
Publicado: (2021)

COVID-19 Masquerading as Autoimmune Hepatitis (AIH) Flare—The First Report()
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Considering direct-acting antivirals to cure hepatitis C virus during pregnancy: is this the last treatment frontier?
por: Kushner, Tatyana, et al.
Publicado: (2019)

Exercise Caution with ChAdOx1 COVID-19 Vaccination in Chronic Budd-Chiari Syndrome with a Thrombophilic Genetic Predisposition
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients
por: Al-Busafi, Said A., et al.
Publicado: (2017)

COVID-19 vaccine induced autoimmune hepatitis-a first case series from India
por: Iyengar, Sowmya, et al.
Publicado: (2022)

Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
por: Sharma, Mithun, et al.
Publicado: (2021)

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022)

Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India
por: Gupta, Varun, et al.
Publicado: (2017)

Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review
por: Kulkarni, Anand V, et al.
Publicado: (2020)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Direct-acting antiviral retreatment patterns for hepatitis C
por: Hasan, Shaquib Al, et al.
Publicado: (2022)

Hairdye-Induced Hepatitis: An Unusal Cause of Acute Hepatitis
por: Gokak, Varadaraj P., et al.
Publicado: (2009)

Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects
por: Sharma, Mithun, et al.
Publicado: (2020)

Author Correction: Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects
por: Sharma, Mithun, et al.
Publicado: (2021)

Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure
por: Mohammed Abdul, Mubeen Khan, et al.
Publicado: (2020)

Psychiatric treatment considerations with direct acting antivirals in hepatitis C
por: Sockalingam, Sanjeev, et al.
Publicado: (2013)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
por: Ahmed, Asma, et al.
Publicado: (2015)

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
por: McGlynn, Elizabeth A., et al.
Publicado: (2019)

Viral hepatitis: A global burden needs future directions for the management
por: Verma, Henu Kumar, et al.
Publicado: (2022)

Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
por: Khaliq, Saba, et al.
Publicado: (2018)

Patients with decompensated cirrhosis and liver transplant recipients demonstrate poor humoral and cellular immune response against COVID-19 vaccine
por: Kulkarni, Anand, et al.
Publicado: (2022)

Hepatitis C Virus-associated Membranoproliferative Glomerulonephritis Treated with Directly Acting Antiviral Therapy
por: Nayak, S., et al.
Publicado: (2018)

Direct-acting antivirals for acute hepatitis C in HIV-infected MSM
por: Millard, James Daniel, et al.
Publicado: (2016)

Management of hepatitis C genotype 4 in the directly acting antivirals era
por: Hathorn, Emma, et al.
Publicado: (2016)

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
por: Yoo, Eric R., et al.
Publicado: (2016)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
por: Hill, Andrew, et al.
Publicado: (2018)

Hepatitis C virus infection in children in the era of direct-acting antiviral
por: Pawlowska, Malgorzata, et al.
Publicado: (2018)

The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C
por: Yang, Christine Hong Ting, et al.
Publicado: (2017)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
por: Egmond, Elfi, et al.
Publicado: (2019)

Current therapy for chronic hepatitis C: The role of direct-acting antivirals
por: Li, Guangdi, et al.
Publicado: (2017)

Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges
por: Zeng, Haiyan, et al.
Publicado: (2020)

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
por: Zhang, Hang, et al.
Publicado: (2023)

Outcomes of Liver Transplant Recipients Infected with COVID-19 is Similar to Non- liver Transplant Patients
por: Kulkarni, Dr Anand V., et al.
Publicado: (2022)

Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis
por: Kulkarni, Anand V., et al.
Publicado: (2021)

Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
por: Cárdaba-García, María E., et al.
Publicado: (2021)

Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iinm7i2jg9kkckranubmigp058